EUVIMEDEUVIMED entdecken
Crossref

Nocturia as a clinical marker of cardiovascular risk in obstructive sleep apnoea

Simon C Graffen, Yu Sun Bin, Kristina Kairaitis, John R Wheatley, Brendon J Yee, Amanda Piper, Philip De Chazal, Andrew S L Chan, Peter A Cistulli, Sydney Sleep Biobank Investigators

Sleep Medicine · 2026-12 · 148 · 109188

DOI: 10.1016/j.sleep.2026.109188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sleep Medicine, 2026-12. Verfasst von Simon C Graffen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, Sydney, Australia. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Nocturia, Cardiovascular Diseases, Heart Disease Risk Factors. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Nocturia is commonly reported in obstructive sleep apnoea (OSA). Based on the underlying mechanism, involving atrial natriuretic peptide release from the cardiac atria in response to exaggerated intrathoracic pressure swings, we hypothesised that nocturia may serve as a clinical marker identifying individuals with increased cardiovascular disease (CVD) risk. METHODS: We analysed data from the Sydney Sleep Biobank for participants aged 30-74 years, with diagnosed OSA (AHI >5), with adequate data to calculate an office-based Framingham Risk Score (FRS) Nocturia was indicated on the Pittsburgh Sleep Quality Index. We compared cardiovascular risk scores between those with nocturia disturbing sleep 3 or more times per week, or less often. RESULTS: Six hundred and three patients with untreated OSA (67.5% male, mean age 54.2 years [SD 11.7], mean BMI 32.3 kg/m2 [SD 8.3]) were included. Fifty-one percent reported significant nocturia. Pre-existing CVD was reported in 12.4%, FRS was low in 13.6%, moderate in 38.6%, and high in 35.3%. Nocturia was significantly associated with increased cardiovascular risk and existing CVD (χ2 = 15.9, p < 0.001). On logistic regression, nocturia was associated with high CVD risk (OR 1.79, 95% CI 1.26-2.55) and this remained significant even with consideration of potential confounders (OR 1.72, 95% CI 1.18-2.53). On sex-stratified logistic regression this association remained significant in men (2.48; 1.62-3.81) but was not observed in women (0.96; 0.47 - 1.98). CONCLUSION: Nocturia may represent a readily identifiable clinical phenotype associated with elevated cardiovascular risk in men with OSA, although prospective studies are required to confirm its predictive value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, ObstructiveNocturiaCardiovascular DiseasesHeart Disease Risk FactorsHumansMaleMiddle AgedFemaleAdultAgedBiomarkersRisk Factors

Stichwörter der Autor:innen

Cardiovascular riskNocturiaObstructive sleep apnoeaSleep disordered breathing

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, Sydney, Australia.
  • Sleep Research Group, Charles Perkins Centre, University of Sydney, Camperdown, NSW, Australia; Northern Clinical School, Faculty of Medicine and Health, University of Sydney, NSW, Australia.
  • Ludwig Engel Centre for Respiratory Research, Westmead Institute for Medica Research, Westmead, NSW, Australia; Department of Respiratory and Sleep Medicine, Westmead Hospital, Westmead, NSW, Australia; Westmead Clinica…
  • Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Central Clinical School, Faculty of Medicine and Health, University of Sydney, NSW, Australia; Woolcock Institute o…
  • Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Central Clinical School, Faculty of Medicine and Health, University of Sydney, NSW, Australia.
  • Sleep Research Group, Charles Perkins Centre, University of Sydney, Camperdown, NSW, Australia; School of Biomedical Engineering, The University of Sydney, Darlington, NSW, Australia.

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Graffen, S. C., Bin, Y. S., Kairaitis, K., Wheatley, J. R., Yee, B. J., Piper, A., De Chazal, P., Chan, A. S. L., Cistulli, P. A., & Sydney Sleep Biobank Investigators (2026). Nocturia as a clinical marker of cardiovascular risk in obstructive sleep apnoea. Sleep Medicine, 148, 109188. https://doi.org/10.1016/j.sleep.2026.109188

Vancouver

Graffen SC, Bin YS, Kairaitis K, Wheatley JR, Yee BJ, Piper A, et al. Nocturia as a clinical marker of cardiovascular risk in obstructive sleep apnoea. Sleep Medicine. 2026;148:109188. doi:10.1016/j.sleep.2026.109188

BibTeX
@article{Graffen2026,
  author = {Graffen, Simon C and Bin, Yu Sun and Kairaitis, Kristina and Wheatley, John R and Yee, Brendon J and Piper, Amanda and De Chazal, Philip and Chan, Andrew S L and Cistulli, Peter A and Sydney Sleep Biobank Investigators, Sydney Sleep Biobank Investigators},
  title = {Nocturia as a clinical marker of cardiovascular risk in obstructive sleep apnoea},
  journal = {Sleep Medicine},
  year = {2026},
  volume = {148},
  pages = {109188},
  doi = {10.1016/j.sleep.2026.109188}
}
Kostenlos starten →